EUVIMEDEUVIMED entdecken
Crossref

Self-Assembling Amphiphilic PROTACs: A Chemical Strategy for Improved EGFR-Targeted Protein Degradation

Junhui Ma iD, Lei Fang iD, Yu Wu iD, Hui Jiao iD, Guangya Xiang, Xiang Ma iD

Journal of Medicinal Chemistry · 25.06.2026 · 69 (12) · 14866-14884

DOI: 10.1021/acs.jmedchem.6c00971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 12.06.2026. Verfasst von Junhui Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Henan University, Kaifeng 475004, China. Hauptthemen laut MEDLINE: Nanoparticles, Antineoplastic Agents, Surface-Active Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Science and Technology Program of Guizhou Province, National Natural Science Foundation of China, Tongren Polytechnic College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis-targeting chimeras (PROTACs) are attractive targeted protein degradation modalities, while their clinical advancement is limited by high molecular weight, suboptimal bioavailability, low cellular permeability, and unsatisfactory in vivo efficacy. Herein, we developed a self-assembled nanoparticle system (PRO NPs) constructed from amphiphilic PROTACs. Owing to their intrinsic amphiphilicity, PRO NPs can spontaneously assemble into stable nanoparticles without external excipients, simplifying fabrication and alleviating carrier-associated toxicity. Compared with the free EGFR-targeting PROTAC, PRO NPs exhibited enhanced aqueous solubility and efficient EGFR degradation in HCC827 cells. In vivo, PRO NPs functionalized with hyaluronic acid (HA) through electrostatic adsorption could actively accumulate at tumor sites via CD44-mediated targeting, exerting potent antitumor efficacy (TGI = 76.8%) with reduced systemic toxicity. Collectively, these findings provide novel insights into nano-PROTAC design and a promising strategy for the development of targeted protein degradation therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesAntineoplastic AgentsSurface-Active AgentsHumansProteolysis Targeting ChimeraErbB ReceptorsAnimalsProteolysisCell Line, TumorHyaluronic AcidMice

Substanzen

Proteolysis Targeting ChimeraErbB ReceptorsAntineoplastic AgentsEGFR protein, humanHyaluronic AcidSurface-Active Agents

Autor:innen und Institutionen

  • School of Pharmacy, Henan University, Kaifeng 475004, China.
  • School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
  • School of Pharmacy, Tongren Polytechnic College, Tongren, Guizhou 554300, China.
  • The Higher Education Edible and Medicinal Fungi Engineering Research Center of Guizhou Province, Tongren, Guizhou 554300, China.

ORCID-Profile: Junhui Ma, Lei Fang, Yu Wu, Hui Jiao, Xiang Ma

Förderung

  • Science and Technology Program of Guizhou Province
  • National Natural Science Foundation of China
  • Tongren Polytechnic College

Zitieren

APA

Ma, J., Fang, L., Wu, Y., Jiao, H., Xiang, G., & Ma, X. (2026). Self-Assembling Amphiphilic PROTACs: A Chemical Strategy for Improved EGFR-Targeted Protein Degradation. Journal of Medicinal Chemistry, 69(12), 14866-14884. https://doi.org/10.1021/acs.jmedchem.6c00971

Vancouver

Ma J, Fang L, Wu Y, Jiao H, Xiang G, Ma X. Self-Assembling Amphiphilic PROTACs: A Chemical Strategy for Improved EGFR-Targeted Protein Degradation. Journal of Medicinal Chemistry. 2026;69(12):14866-14884. doi:10.1021/acs.jmedchem.6c00971

BibTeX
@article{Ma2026,
  author = {Ma, Junhui and Fang, Lei and Wu, Yu and Jiao, Hui and Xiang, Guangya and Ma, Xiang},
  title = {Self-Assembling Amphiphilic PROTACs: A Chemical Strategy for Improved EGFR-Targeted Protein Degradation},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {12},
  pages = {14866--14884},
  doi = {10.1021/acs.jmedchem.6c00971}
}
Kostenlos starten →